Establishes a committee to study the feasibility of experimental treatment centers in New Hampshire and necessary oversight.

The bill establishes a committee to study the feasibility of establishing experimental treatment centers in New Hampshire and the oversight required. The committee will include members from the senate and house of representatives, and will gather information from various sources including state agencies, current operators, and experts in FDA approval and drug manufacturing. The committee will research oversight challenges and outcomes from other states, and will report findings and recommendations by November 1, 2026.

Establishes a committee to study the feasibility of experimental treatment centers in New Hampshire and necessary oversight.

The bill establishes a committee to study the feasibility of establishing experimental treatment centers in New Hampshire and the oversight required. The committee will include members from the senate and house of representatives, and will gather information from various sources including state agencies, current operators, and experts in FDA approval and drug manufacturing. The committee will research oversight challenges and outcomes from other states, and will report findings and recommendations by November 1, 2026.